Getting medical marijuana laws right

Submitted by Carlyn Zwarenstein on July 25, 2014 - 21:47

An interesting piece today relating to Canada's evolving laws on medical marijuana.

CBC News on Joep Lange, triple therapy for HIV, and Dr. Lange''s links to the Canadian research community

Submitted by Carlyn Zwarenstein on July 21, 2014 - 15:34

"If we can get cold Coca–Cola and beer to every remote corner of Africa, it should not be impossible to do the same with drugs."

More on Joep Lange, who died on Malaysia Airlines Flight MH17:

http://www.cbc.ca/news/world/malaysia-airlines-flight-mh17-aids-scientis...

Healthcare system woes

Submitted by Carlyn Zwarenstein on July 18, 2014 - 13:12

A recent report from the Commonwealth Fund, a non-profit, private American foundation, compares the U.S. healthcare system with a number of its international counterparts.

Drug development in the sharing economy

Submitted by Carlyn Zwarenstein on June 23, 2014 - 13:55

Sharing—what a concept. With scientific research tending in two directions—on one hand, towards more proprietary knowledge and more expensive and limited access, and on the other, towards open data and open access publications—it is interesting to note a new private-public partnership based in Toronto and New York that will provide completely open access to anyone who wants to use its structural genomics data. Is this what real sharing of information should look like?

Media release: Guide to noninferiority trials for novel therapies

Submitted by Carlyn Zwarenstein on May 6, 2014 - 06:42

A clinician’s guide to the assessment and interpretation of noninferiority trials for novel therapies

Open Medicine
A peer-reviewed, independent, open-access journal.

FOR IMMEDIATE RELEASE

Open Access is for patients too.

Submitted by Carlyn Zwarenstein on April 30, 2014 - 21:17
Topics: 

A flurry of study on the topic of open access--always, of course, of special interest around here--as I prepare a talk for a festival of arts and science in Toronto (more on that, to come), on the experience our journal has had with open access from shortly after the concept itself was developed and named. I am coming across all sorts of fascinating things in the process.

The costs of open access publishing

Submitted by Carlyn Zwarenstein on April 29, 2014 - 16:13
Topics: 

A recent, information-rich report from the Wellcome Trust: http://blog.wellcome.ac.uk/2014/03/28/the-cost-of-open-access-publishing...

 

Low tech biotech

Submitted by Carlyn Zwarenstein on April 25, 2014 - 22:52

Citizen science and the DIY (do-it-yourself) movement combine in the quest to create simple, low-cost, assembled-from-basic-materials equipment capable of carrying out sophisticated diagnostic tests or other applications. Open access data can be an important component of making such equipment cost effective. 

Pages